EULAR/ACR Systemic Lupus Erythematosus Classification Criteria Update
EULAR and ACR jointly funded and collaborated on creating a set of criteria that can be used to more accurately identify patients with SLE for inclusion in clinical trials.
Sle
Impact of Remission, Low Disease Activity on Outcomes in Lupus
While a treat to target strategy has been proposed for managing SLE, the impact of possible disease outcomes has not been fully evaluated.
Venetoclax Safe, Effective in Women With Systemic Lupus Erythematosus
Use of the anti-apoptotic protein B-cell lymphoma 2 inhibitor venetoclax reduced total lymphocyte and disease-relevant B cells in women with SLE.
Guidelines for Peri-Op Care in Rheumatic Disease
These guidelines address the use of antirheumatic drugs for adults with RA, SpA, JIA, and SLE undergoing THA or TKA.
Optimal ANA Cutoff Titer as Entry Criterion for SLE Classification
The new approach in development proposes the use of positive indirect immunofluorescence ANA (IIF-ANA) as an entry criterion for SLE classification.
Risk Factors for Depression in Patients With Childhood-Onset Lupus
Increased disease activity, poorer physical functioning, and lower education attainment were major predictors for depression in adulthood.
Biomarkers of Pulmonary Arterial Hypertension Risk in SLE
Meta-analysis supports anti-RNP and anti-Sm antibodies as serological biomarkers of PAH risk in patients with systemic lupus erythematosus.
Patients With Systemic Lupus Erythematosus and Cognitive Dysfunction Prevalence
MOCA is more effective than the Mini-Mental State Examination at detecting cognitive dysfunction.
Patients With Lupus Have Poor Quality of Sleep, Quality of Life
The majority of patients with systemic lupus erythematosus have poor quality of sleep.
Steroid Dosage as Risk Factor for Osteonecrosis in Patients With SLE
Cumulative steroid dosage is a risk factor for the development of osteonecrosis.
- Loading...
Loading...
Next post in Systemic Lupus Erythematosus
Loading... 
Loading...